Division of Epidemiology of Microbial Diseases, Yale University School of Public Health, 60 College Street, P.O. Box 208034, New Haven, CT 06520-8034, USA.
AIDS Behav. 2011 Jan;15(1):45-57. doi: 10.1007/s10461-010-9775-z.
We examined the prevalence of HIV disclosure to sexual partners by HIV-positive drug injectors (IDUs) in St. Petersburg, Russia and compared the magnitude and direction of associations of condom use with awareness of one's HIV infection and disclosure to partners. Among 157 HIV-infected participants, awareness of infection at time of last intercourse was associated with condom use with partners perceived to be HIV-negative (aOR 6.68, 95% CI 1.60-27.88). Among the 70 participants aware of their infection prior to enrolment, disclosure to potentially uninfected sexual partners was independently and negatively associated with condom use (aOR 0.13, 95% CI 0.02-0.66). Disclosure was independently associated with having injected ≥ 9 years (aOR 6.04, 95% CI 1.53-23.77) and partnership with another IDU (aOR 3.61, 95% CI 1.44-9.06) or HIV-seropositive (aOR 45.12, 95% CI 2.79-730.46). Scaling up HIV testing services and interventions that increase the likelihood of individuals receiving their test results is recommended.
我们调查了俄罗斯圣彼得堡 HIV 阳性吸毒者（IDU）向性伴侣透露 HIV 状况的流行率，并比较了与伴侣使用避孕套与对 HIV 感染的认识和对伴侣的披露之间的关联的大小和方向。在 157 名感染 HIV 的参与者中，在最后一次性交时意识到感染与与被认为 HIV 阴性的伴侣使用避孕套有关（调整后的优势比[aOR]6.68，95%置信区间[CI]1.60-27.88）。在 70 名在入组前就意识到自己感染的参与者中，向可能未感染的性伴侣披露与避孕套使用呈独立负相关（aOR 0.13，95%CI 0.02-0.66）。披露与注射毒品≥9 年（aOR 6.04，95%CI 1.53-23.77）以及与另一名 IDU（aOR 3.61，95%CI 1.44-9.06）或 HIV 血清阳性（aOR 45.12，95%CI 2.79-730.46）的伴侣有关。建议扩大 HIV 检测服务和干预措施，以增加个人获得检测结果的可能性。
Zotero 插件